Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Recruiting now

Conditions studied: Metastatic Breast Cancer, Lobular Breast Carcinoma

In brief

This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.

Key facts

Study ID

NCT05964504

Run by

University of California, San Francisco

People needed

12

Starts

2023-12-20

Expected to finish

2036-02-28

Last updated by the study team

2026-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically confirmed invasive lobular carcinoma. Mixed lobular/ductal cancer is allowed.
• Age >=18 years
• Any receptor subtype.
• Ability to understand a written informed consent document, and the willingness to sign it.

You may not qualify if…

• Stage I-III breast cancer.
• Lack of lobular histology on tumor biopsy.
• Other active cancer (prior treated cancer with no current evidence of disease is allowed).

Where it is running

• University of California, San Diego — San Diego, California, United States (enrolling)
• University of California, San Francisco — San Francisco, California, United States (enrolling)
• Abramson Cancer Center — Philadelphia, Pennsylvania, United States (enrolling)
• MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.